181 related articles for article (PubMed ID: 15531098)
1. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.
Tamás A; Gábriel R; Rácz B; Dénes V; Kiss P; Lubics A; Lengvári I; Reglodi D
Neurosci Lett; 2004 Nov; 372(1-2):110-3. PubMed ID: 15531098
[TBL] [Abstract][Full Text] [Related]
2. Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.
Atlasz T; Szabadfi K; Reglodi D; Kiss P; Tamás A; Tóth G; Molnár A; Szabó K; Gábriel R
Ann N Y Acad Sci; 2009 Apr; 1163():348-52. PubMed ID: 19456357
[TBL] [Abstract][Full Text] [Related]
3. Effects of systemic PACAP treatment in monosodium glutamate-induced behavioral changes and retinal degeneration.
Kiss P; Tamás A; Lubics A; Lengvári I; Szalai M; Hauser D; Horvath ZS; Racz B; Gabriel R; Babai N; Toth G; Reglódi D
Ann N Y Acad Sci; 2006 Jul; 1070():365-70. PubMed ID: 16888193
[TBL] [Abstract][Full Text] [Related]
4. Early postnatal enriched environment decreases retinal degeneration induced by monosodium glutamate treatment in rats.
Szabadfi K; Atlasz T; Horváth G; Kiss P; Hamza L; Farkas J; Tamás A; Lubics A; Gábriel R; Reglodi D
Brain Res; 2009 Mar; 1259():107-12. PubMed ID: 19171125
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
[TBL] [Abstract][Full Text] [Related]
7. Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.
Babai N; Atlasz T; Tamás A; Reglodi D; Tóth G; Kiss P; Gábriel R
Ann N Y Acad Sci; 2006 Jul; 1070():149-55. PubMed ID: 16888157
[TBL] [Abstract][Full Text] [Related]
8. Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats.
Kiss P; Atlasz T; Szabadfi K; Horvath G; Griecs M; Farkas J; Matkovits A; Toth G; Lubics A; Tamas A; Gabriel R; Reglodi D
Neurosci Lett; 2011 Jan; 487(3):400-5. PubMed ID: 21050880
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
[TBL] [Abstract][Full Text] [Related]
10. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
[TBL] [Abstract][Full Text] [Related]
11. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.
Babai N; Atlasz T; Tamás A; Reglödi D; Tóth G; Kiss P; Gábriel R
Neurotox Res; 2005 Nov; 8(3-4):227-33. PubMed ID: 16371317
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion.
Rácz B; Tamás A; Kiss P; Tóth G; Gasz B; Borsiczky B; Ferencz A; Gallyas F; Roth E; Reglodi D
Ann N Y Acad Sci; 2006 Jul; 1070():507-11. PubMed ID: 16891269
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
[TBL] [Abstract][Full Text] [Related]
15. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B
J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936
[TBL] [Abstract][Full Text] [Related]
16. Urocortin 2 treatment is protective in excitotoxic retinal degeneration.
Szabadfi K; Kiss P; Reglodi D; Fekete EM; Tamas A; Danyadi B; Atlasz T; Gabriel R
Acta Physiol Hung; 2014 Mar; 101(1):67-76. PubMed ID: 24311224
[TBL] [Abstract][Full Text] [Related]
17. Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract.
Hannibal J; Hindersson P; Ostergaard J; Georg B; Heegaard S; Larsen PJ; Fahrenkrug J
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4202-9. PubMed ID: 15505076
[TBL] [Abstract][Full Text] [Related]
18. Effect of monosodium glutamate on retinal vessel development and permeability in rats.
Bellhorn RW; Lipman DA; Confino J; Burns MS
Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):237-47. PubMed ID: 7251307
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons.
Shintani N; Suetake S; Hashimoto H; Koga K; Kasai A; Kawaguchi C; Morita Y; Hirose M; Sakai Y; Tomimoto S; Matsuda T; Baba A
Regul Pept; 2005 Mar; 126(1-2):123-8. PubMed ID: 15620425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
